Astrana Health stockholders approve 2024 equity plan, 1 million added shares, and elect nine directors
At its June 10, 2026 annual meeting, Astrana Health stockholders approved an amended and restated 2024 Equity Incentive Plan that adds 1,000,000 shares to the reserve and extends the plan to March 24, 2036. All nine director nominees were elected, and the auditor ratification, advisory pay vote, and plan approval all passed, which matters to shareholders because it sets the company's equity compensation framework for the next decade.
Key points
- Plan amendment adds 1,000,000 shares to the reserve and extends the term to March 24, 2036.
- Nine directors were elected, each to serve until the 2027 annual meeting.
- Ernst & Young LLP ratified as auditor for fiscal 2026 with 43,722,509 votes for.
- Shareholders holding about 78.6% of eligible votes were present, and the advisory executive pay proposal passed with 34,119,199 votes for.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:55 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on June 10, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.